Abstract
Extended cardiac monitoring is used to detect atrial fibrillation (AF) in high-risk populations, including those with a history of cryptogenic stroke. Despite demonstrated effectiveness in AF detection, randomized trials have not clearly demonstrated a reduction in stroke and systemic embolism (SSE) or transient ischemic attack (TIA). We performed a systematic review and meta-analysis of randomized trials evaluating extended monitoring versus usual care on reduction of stroke/SSE and TIA (PROSPERO #CRD42021277611).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
